SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SRGN ( Seragen, Inc.)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: AL RICE who wrote (27)2/6/1998 11:25:00 PM
From: Dr. John M. de Castro  Read Replies (3) of 52
 
Wow! SRGN has doubled in value in the last 3 days after the announcement that their BLA was accepted as fileable by the FDA.

biz.yahoo.com

This is good news. But, it is not good enough to explain such a surge. Even the company admits that this is a drug to treat a rare ailment and there won't be a very large market.

Does anyone have an explanation?

John de C
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext